Company intelligence / Profile preview
D-10 Therapeutics
Torrance, California, United Statesd10therapeutics.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
Developing a novel therapy for sickle cell disease that prevents damage to blood vessels by blocking receptors that cause sickle cells to adhere to blood vessel walls and inducing relaxation of smooth muscle cells to widen blood vessels
- Therapeutic areas
- Hematology
- Modalities
- Monoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
IQVIA (for filing priority pediatric review voucher)
Beyond the preview
Go deeper on D-10 Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on D-10 Therapeutics.